Literature DB >> 25597313

Role of p53 in systemic autoimmune diseases.

Hiroaki Takatori1, Hirotoshi Kawashima1, Kotaro Suzuki1, Hiroshi Nakajima1.   

Abstract

The tumor suppressor p53 has been shown to play a central role in tumor suppression by inducing apoptosis, cell cycle arrest, senescence, and DNA repair. In addition, recent observations indicate that the dysfunction of p53 is associated with the development of autoimmune diseases. In this review, we discuss the importance of p53 in various human and murine autoimmune diseases. We also discuss the role of p53 in controlling the balance between Th17 cells and Tregs, the alteration of which is shown to be involved in the development of autoimmunity. It is postulated that the selective restoration of p53 function in T cells could be applicable to the treatment of systemic autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25597313     DOI: 10.1615/critrevimmunol.2014012193

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  20 in total

1.  Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population.

Authors:  Jie Yang; Ji-Min Zhu; Song Wu; Jing Li; Ming-Rui Wang; Ting-Ting Wang; Yu-Wei Lu
Journal:  Rheumatol Int       Date:  2017-02-09       Impact factor: 2.631

Review 2.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

3.  Regulation of autoimmune disease by the E3 ubiquitin ligase Itch.

Authors:  Emily K Moser; Paula M Oliver
Journal:  Cell Immunol       Date:  2019-04-05       Impact factor: 4.868

4.  Deficiency of p53 Causes the Inadequate Expression of miR-1246 in B Cells of Systemic Lupus Erythematosus.

Authors:  Qing Zhang; Yu Liu; Jieyue Liao; Ruifang Wu; Yi Zhan; Peng Zhang; Shuangyan Luo
Journal:  J Immunol       Date:  2022-09-09       Impact factor: 5.426

5.  LncRNA RUNX1-IT1 affects the differentiation of Th1 cells by regulating NrCAM transcription in Graves' disease.

Authors:  Feng-Jiao Huang; Yan-Ling Liu; Jiao Wang; Ying-Ying Zhou; Shui-Ying Zhao; Gui-Jun Qin
Journal:  Cell Cycle       Date:  2022-02-27       Impact factor: 5.173

Review 6.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

7.  Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53.

Authors:  Kyoung Wan Yoon; Sanguine Byun; Eunjeong Kwon; So-Young Hwang; Kiki Chu; Masatsugu Hiraki; Seung-Hee Jo; Astrid Weins; Samy Hakroush; Angelika Cebulla; David B Sykes; Anna Greka; Peter Mundel; David E Fisher; Anna Mandinova; Sam W Lee
Journal:  Science       Date:  2015-07-31       Impact factor: 47.728

8.  TGF-β suppresses RasGRP1 expression and supports regulatory T cell resistance against p53-induced CD28-dependent T-cell apoptosis.

Authors:  Mariko Takami; Christina Cunha; Shinichiro Motohashi; Toshinori Nakayama; Makio Iwashima
Journal:  Eur J Immunol       Date:  2018-10-24       Impact factor: 5.532

9.  Modulation of PKM activity affects the differentiation of TH17 cells.

Authors:  Scott M Seki; Kacper Posyniak; Rebecca McCloud; Dorian A Rosen; Anthony Fernández-Castañeda; Rebecca M Beiter; Vlad Serbulea; Sarah C Nanziri; Nikolas Hayes; Charles Spivey; Lelisa Gemta; Timothy N J Bullock; Ku-Lung Hsu; Alban Gaultier
Journal:  Sci Signal       Date:  2020-10-27       Impact factor: 8.192

Review 10.  The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target.

Authors:  Alessandra Fierabracci; Marsha Pellegrino
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.